Literature DB >> 16425036

Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters.

Silvia Calpe1, Erika Erdos, Gongxian Liao, Ninghai Wang, Svend Rietdijk, Maria Simarro, Beata Scholtz, Jill Mooney, Chang Hoon Lee, Min Sun Shin, Eva Rajnavölgyi, John Schatzle, Herbert C Morse, Cox Terhorst, Arpad Lanyi.   

Abstract

Human EAT-2 (SH2D1B) and SLAM-associated protein (SAP) (SH2D1A) are single SH2-domain adapters, which bind to specific tyrosine residues in the cytoplasmic tail of six signaling lymphocytic activation molecule (SLAM) (SLAMF1)-related receptors. Here we report that, unlike in humans, the mouse and rat Eat2 genes are duplicated with an identical genomic organization. The coding regions of the mouse Eat2a and Eat2b genes share 91% identity at the nucleotide level and 84% at the protein level; similarly, segments of introns are highly conserved. Whereas expression of mouse Eat2a mRNA was detected in multiple tissues, Eat2b was only detectable in mouse natural killer cells, CD8+ T cells, and ovaries, suggesting a very restricted tissue expression of the latter. Both the EAT-2A and EAT-2B coimmunoprecipitated with mouse SLAM in transfected cells and augmented tyrosine phosphorylation of the cytoplasmic tail of SLAM. Both EAT-2A and EAT-2B bind to the Src-like kinases Fyn, Hck, Lyn, Lck, and Fgr, as determined by a yeast two-hybrid assay. However, unlike SAP, the EAT-2 proteins bind to their kinase domains and not to the SH3 domain of these kinases. Taken together, the data suggest that both EAT-2A and EAT-2B are adapters that recruit Src kinases to SLAM family receptors using a mechanism that is distinct from that of SAP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425036     DOI: 10.1007/s00251-005-0056-3

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  40 in total

Review 1.  Positive and negative regulation of T-cell activation by adaptor proteins.

Authors:  G A Koretzky; P S Myung
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 2.  Adaptors and linkers in T and B cells.

Authors:  Luca Simeoni; Stefanie Kliche; Jonathan Lindquist; Burkhart Schraven
Journal:  Curr Opin Immunol       Date:  2004-06       Impact factor: 7.486

3.  Defective B cell responses in the absence of SH2D1A.

Authors:  Massimo Morra; Robert A Barrington; Ana C Abadia-Molina; Susumo Okamoto; Aimee Julien; Charles Gullo; Anuj Kalsy; Matthew J Edwards; Gang Chen; Rosanne Spolski; Warren J Leonard; Brigitte T Huber; Persephone Borrow; Christine A Biron; Abhay R Satoskar; Michael C Carroll; Cox Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

4.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

5.  Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor.

Authors:  Romain Roncagalli; James E R Taylor; Shaohua Zhang; Xiaochu Shi; Riyan Chen; Mario-Ernesto Cruz-Munoz; Luo Yin; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

6.  Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.

Authors:  J Sayós; M Martín; A Chen; M Simarro; D Howie; M Morra; P Engel; C Terhorst
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

7.  A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.

Authors:  Yun Dai; Mohamed Rahmani; Seth J Corey; Paul Dent; Steven Grant
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

8.  SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.

Authors:  Maria Simarro; Arpad Lanyi; Duncan Howie; Florence Poy; Joost Bruggeman; Michelle Choi; Janos Sumegi; Michael J Eck; Cox Terhorst
Journal:  Int Immunol       Date:  2004-04-13       Impact factor: 4.823

9.  A functional screen in yeast for regulators and antagonizers of heterologous protein tyrosine kinases.

Authors:  G Superti-Furga; K Jönsson; S A Courtneidge
Journal:  Nat Biotechnol       Date:  1996-05       Impact factor: 54.908

10.  2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.

Authors:  Kyung-Mi Lee; Megan E McNerney; Susan E Stepp; Porunelloor A Mathew; John D Schatzle; Michael Bennett; Vinay Kumar
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  10 in total

1.  Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy.

Authors:  Yasser A Aldhamen; Sergey S Seregin; Charles F Aylsworth; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2013-12-27       Impact factor: 4.823

Review 2.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 3.  SLAM-family receptors: immune regulators with or without SAP-family adaptors.

Authors:  André Veillette
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 4.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells.

Authors:  C M Cuda; L Zeumer; E S Sobel; B P Croker; L Morel
Journal:  Genes Immun       Date:  2010-05-06       Impact factor: 2.676

6.  EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase Cγ, Ca++, and Erk, leading to granule polarization.

Authors:  Luis-Alberto Pérez-Quintero; Romain Roncagalli; Huaijian Guo; Sylvain Latour; Dominique Davidson; André Veillette
Journal:  J Exp Med       Date:  2014-03-31       Impact factor: 14.307

Review 7.  Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.

Authors:  Masafumi Taniwaki; Mihoko Yoshida; Yosuke Matsumoto; Kazuho Shimura; Junya Kuroda; Hiroto Kaneko
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-02-15       Impact factor: 2.576

8.  SLAMF6 clustering is required to augment T cell activation.

Authors:  Matthew A Dragovich; Kieran Adam; Marianne Strazza; Anna S Tocheva; Michael Peled; Adam Mor
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

Review 9.  Responses to Microbial Challenges by SLAMF Receptors.

Authors:  Boaz Job van Driel; Gongxian Liao; Pablo Engel; Cox Terhorst
Journal:  Front Immunol       Date:  2016-01-20       Impact factor: 7.561

10.  Fine specificity and molecular competition in SLAM family receptor signalling.

Authors:  Timothy J Wilson; Lee I Garner; Clive Metcalfe; Elliott King; Stefanie Margraf; Marion H Brown
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.